bw a868c has been researched along with phenyl acetate in 1 studies
| Studies (bw a868c) | Trials (bw a868c) | Recent Studies (post-2010) (bw a868c) | Studies (phenyl acetate) | Trials (phenyl acetate) | Recent Studies (post-2010) (phenyl acetate) |
|---|---|---|---|---|---|
| 47 | 0 | 11 | 41,232 | 1,558 | 8,330 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, I; Futaki, N; Hashimoto, Y; Honma, Y; Inoue, T; Koizumi, C; Nakaike, S; Nakanishi, Y; Ono, N; Sakurai, T; Sugimoto, M; Takahashi, N; Takaoka, A; Tanami, T; Yagi, M | 1 |
1 other study(ies) available for bw a868c and phenyl acetate
| Article | Year |
|---|---|
Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice.
Topics: Acetates; Animals; Antipruritics; Concanavalin A; Cyclohexanes; Cytokines; Dermatitis, Atopic; Dexamethasone; Humans; Hydantoins; Immunosuppressive Agents; Inflammation; Male; Mice; Platelet Aggregation; Prostaglandin D2; Pruritus; Receptors, Immunologic; Receptors, Prostaglandin; Skin; Sulfhydryl Compounds; Tacrolimus; Wound Healing | 2007 |